PFM Health Sciences, LP - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
PFM Health Sciences, LP ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$19,299,000
+128.4%
344,868
+111.2%
0.70%
+116.8%
Q2 2022$8,451,000
-59.6%
163,280
-43.3%
0.32%
-58.8%
Q1 2022$20,922,000
-0.7%
287,909
+61.5%
0.78%
+9.1%
Q4 2021$21,073,000
-11.9%
178,2220.0%0.72%
+2.0%
Q3 2021$23,908,000
-43.9%
178,222
-32.3%
0.70%
-47.3%
Q2 2021$42,618,000
+86.9%
263,222
-7.3%
1.34%
+91.8%
Q1 2021$22,801,000284,1010.70%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders